Characterization of the polymyxin B resistome of Pseudomonas aeruginosa

Lucía Fernández1, Carolina Alvarez-Ortega, Irith Wiegand

  • 1Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, British Columbia, Canada.

Insights

Pseudomonas aeruginosa exhibits limited resistance to polymyxin B, with lipopolysaccharide (LPS) integrity and lipid A modification being key factors. Understanding these cell surface structures is crucial for combating antibiotic resistance.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • Multidrug resistance in Pseudomonas aeruginosa poses a significant threat to human health.
  • Polymyxins are critical last-resort antibiotics, but resistance is emerging.
  • Increased polymyxin use drives the selection of resistant strains.

Purpose of the Study:

  • To identify genes influencing polymyxin B susceptibility in P. aeruginosa.
  • To understand the genetic basis of polymyxin B resistance and susceptibility.
  • To investigate the role of cell surface structures in polymyxin B resistance.

Main Methods:

  • Screening of a comprehensive PA14 mutant library.
  • Analysis of lipopolysaccharide (LPS) structure using SDS-PAGE and Western blots.
  • Assessment of outer membrane permeability in mutant strains.

Main Results:

  • A small polymyxin B resistome was identified, with 17 susceptibility/resistance determinants.
  • Mutants with transposon insertions in LPS-related genes showed increased polymyxin B susceptibility.
  • Altered LPS structure, including core truncation and lack of O-antigen, was observed in susceptible mutants.
  • Increased outer membrane permeability and altered lipid A modification contributed to susceptibility.

Conclusions:

  • LPS integrity and lipid A modification are crucial for polymyxin B resistance in P. aeruginosa.
  • Characterizing genes affecting cell surface structures aids in understanding and combating peptide resistance.
  • This research provides insights into the evolution of antibiotic resistance in clinical settings.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...